West Pharmaceutical ServicesWST
紐約證券 · USD
235.67
+4.58
(+1.98%)
盤中 03/14 03:30 (UTC+8)
03/14 03:30 (UTC+8)
West Pharmaceutical ServicesWST
235.67
+4.58
(+1.98%)
財務數據
損益表
- 7.47
- 7.32
- 6.95
- 7.02
- 7.47
- 7.49
- 6.98
- 7.67
- 8.05
- 8.05
- -0.85
- -2.06
- -5.00
- 0.96
- 6.38
- 0.25
- -6.78
- 9.81
- 4.97
- 0.05
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 805,000 | 804,600 | 766,500 | 698,000 | 748,800 | 746,900 | 702,100 | 695,400 | 732,000 | 747,400 |
營業成本 | 501,100 | 510,300 | 492,600 | 466,100 | 475,200 | 482,200 | 472,100 | 465,200 | 453,800 | 459,100 |
營業毛利 | 303,900 | 294,300 | 273,900 | 231,900 | 273,600 | 264,700 | 230,000 | 230,200 | 278,200 | 288,300 |
營業費用 | 147,300 | 119,800 | 115,000 | - | 114,000 | 103,400 | 103,800 | - | 117,300 | 111,000 |
研發費用 | 21,800 | 17,100 | 19,100 | 16,300 | 18,500 | 15,500 | 17,500 | 17,600 | 18,400 | 16,400 |
推銷及管理費用 | 125,500 | 102,700 | 95,900 | 108,600 | 95,500 | 87,900 | 86,300 | 89,800 | 98,900 | 94,600 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 156,600 | 174,500 | 158,900 | 107,000 | 159,600 | 161,300 | 126,200 | 122,800 | 160,900 | 177,300 |
其他收入及費用 | 4,700 | - | - | 3,900 | 4,500 | 3,900 | 4,000 | 6,200 | 8,500 | 12,600 |
利息費用 | -200 | 200 | 100 | 400 | -800 | 700 | 1,500 | 1,600 | 1,200 | 2,900 |
稅前純益 | 161,500 | 171,900 | 157,000 | 110,500 | 164,900 | 164,500 | 128,700 | 127,400 | 168,200 | 187,000 |
所得稅 | 33,300 | 34,000 | 30,200 | 24,100 | 36,800 | 32,400 | 21,900 | 16,400 | 34,500 | 29,400 |
稅後純益 | 132,100 | 140,000 | 131,800 | 89,800 | 130,100 | 136,000 | 111,300 | 115,300 | 137,000 | 161,300 |
基本每股稅後盈餘(元) | 1.83 | 1.94 | 1.82 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 |
稀釋每股稅後盈餘(元) | 1.82 | 1.92 | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 |
基本平均股數(千股) | 72300.00 | 72200.00 | 72200.00 | 72500.00 | 72700.00 | 72800.00 | 73000.00 | 73500.00 | 74100.00 | 74300.00 |
稀釋平均股數(千股) | 72700.00 | 72600.00 | 72500.00 | 73000.00 | 73300.00 | 73400.00 | 73700.00 | 74300.00 | 75000.00 | 75300.00 |
還原基本每股稅後盈餘(元) | 1.83 | 1.94 | 1.82 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 |
還原稀釋每股稅後盈餘(元) | 1.82 | 1.92 | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 |
還原基本平均股數(千股) | 72,300 | 72,200 | 72,200 | 72,500 | 72,700 | 72,800 | 73,000 | 73,500 | 74,100 | 74,300 |
還原稀釋平均股數(千股) | 72,700 | 72,600 | 72,500 | 73,000 | 73,300 | 73,400 | 73,700 | 74,300 | 75,000 | 75,300 |
EBITDA(千元) | 212,200 | 217,200 | 203,500 | 154,300 | 206,800 | 209,300 | 173,600 | 168,900 | 208,600 | 229,300 |